Strategic Acquisition Enclara Healthcare was involved in a high-profile acquisition by Humana in December 2019, indicating a strong strategic fit in hospice pharmacy and PBM services and potential ongoing integration opportunities with a large payer ecosystem.

Payer Collaboration Humana’s pursuit and eventual acquisition suggests a proven path for payer-provider collaboration, presenting a sales opening to expand partnerships with health plans seeking to enhance hospice pharmacy management and vertical integration.

Niche Focus As a leader in hospice pharmacy and benefit management within the complex care space, Enclara offers a specialized value proposition aimed at improving patient experience, quality, and cost—a compelling angle for health systems pursuing value-based care initiatives.

Tech Enablement The technology stack—Power Apps, Power Automate, Power BI, QlikView, SAS, Tableau, WordPress, Imperva—indicates strong capabilities in data analytics, workflow automation, and secure web presence, usable for selling integrated data-driven care delivery enhancements.

Growth Signals Revenue is reported as under one million dollars with a small employee base, suggesting an opportunity to upsell scalable solutions (integration, analytics, and automation) to larger healthcare organizations and acquirers seeking to expand hospice and end-of-life care management capabilities.